Cumberland Pharmaceuticals Reports 38% Revenue Growth In The First Quarter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cumberland Pharmaceuticals Reports 38% Revenue Growth In The First Quarter

Cumberland Pharmaceuticals (CPIX) Reports In-Line Q1 EPS, Revs Beat

May 14, 2019 4:11 PM EDT

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $10.7 million.

Quarter highlights:

Obtained FDA approval of our Next Generation Caldolor® product featuring a new patented... More